How do I pitch State of Medtech as a podcast guest?

State of Medtech has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.

Who is the host of State of Medtech?

State of Medtech is hosted by Unknown Host. The show is categorised under Health (fitness) and has published 406 episodes.

How many episodes does State of Medtech have?

State of Medtech has published 406 episodes.

What topics does State of Medtech cover?

State of Medtech regularly covers Health, Fitness, Medicine. It sits in the Health category, with a fitness focus.

Is it hard to get booked on State of Medtech?

State of Medtech is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.

Is State of Medtech currently accepting guest pitches?

State of Medtech hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.

How long are State of Medtech episodes?

Episodes of State of Medtech average 50 minutes. a focused format where a clear narrative arc and tight preparation matter most.

What guest credentials does State of Medtech typically look for?

Our data rates State of Medtech's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.

Health

State of Medtech

Hosted by Unknown Host · Health · EN · 406 episodes

Audience: 7

Website

About this Podcast:

State of Medtech is the #1 podcast in medtech and medical devices. Hosted by Omar M. Khateeb, we go inside the business and science of healthcare innovation—with unfiltered interviews from top investors, startup founders, and industry leaders. Each week, we feature candid interviews with: 💼 Top medtech investors & VCs 🧠 Founders of disruptive medical device startups 🧬 Clinicians & industry leaders shaping the future of medicine From go-to-market to M&A, AI to surgical robotics, this is your edge for scaling, funding, and selling in medtech. New episodes weekly.

Pitch Analysis

Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.

Contact path

Verified email

Booking probability

46%

Guest openness

Selective

Verified email on file

80/100

Required Score

Signup to Generate a Pitch

What is State of Medtech?

State of Medtech is a health podcast hosted by Unknown Host, with 406 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

About the host

Unknown Host hosts State of Medtech, a health show with 406 episodes published.

Verified host email: ████████@████.comSign in to unlock →

Recent episodes

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

Episode #407
407. The Sleep Apnea Treatment Renaissance: Amir Reuveny, CEO of Wesper, on Reinventing Diagnosis
Aug 17, 202633 minS1
In this episode, Dr. Amir Reuveny, Founder and CEO of Wesper , joins Omar Khateeb to unpack why sleep diagnostics are becoming increasingly important as the treatment landscape for sleep apnea expands.Amir shares how watching his father struggle with unrecognized sleep apnea eventually connected with his academic work in flexible electronics, leading him to build technology designed around comfortable, clinical-grade home testing. Wesper’s platform uses flexible body sensors and pulse oximetry while generating respiratory data physicians traditionally relied on sleep laboratories to collect. The discussion explores the rise of GLP-1 therapies, CPAP alternatives, oral appliances, surgical treatments, and why a broader range of therapies is increasing the need for accessible diagnosis and ongoing monitoring.Amir and Omar also examine how sleep care is moving beyond specialized sleep medicine into obesity medicine, primary care, ENT, dentistry, and home-based diagnostics , creating a much larger ecosystem around sleep apnea care. The episode offers a compelling look at how materials science, medical devices, software, and changing treatment pathways could move sleep medicine from isolated testing toward more continuous and personalized care. DISCLAIMER This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions. Episode Breakdown: 00:00 Why 80% of Sleep Apnea Cases Go Undiagnosed 01:38 Intro + Meet Amir Reuveny 02:47 From Flexible Electronics to MedTech Founder 03:44 The Personal Story Behind Wesper 05:15 Making Sleep Apnea Testing Easier at Home 06:20 How Flexible Electronics Changed Sleep Testing 09:11 GLP-1s Are Changing Sleep Apnea Treatment 12:08 CPAP, GLP-1s and New Treatment Options 13:38 How Wesper Improves At-Home Sleep Testing 16:09 Inside the Wesper Sleep Testing System 18:14 How Wesper Compares to Traditional Sleep Tests 20:02 Commercializing At-Home Sleep Diagnostics 20:52 How Wesper Reaches Physicians and Health Systems 22:45 Why Sleep Care Is Moving Upstream 23:51 The New Wesper Sleep Ecosystem 25:45 From One-Night Testing to Continuous Monitoring 26:55 Expanding Into Obesity, ENT and Primary Care 28:27 ResMed and the Future of Sleep Tech 29:47 Could Pharma Acquire a Sleep Tech Company? 31:09 New Investors Entering the Sleep Market 31:54 What’s Next for Wesper 32:28 Final Thoughts 32:38 Outro Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis. SUBSCRIBEYouTube: https://www.youtube.com/@thestateofmedtech LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/ FOLLOW THE STATE OF MEDTECHLinkedIn: https://www.linkedin.com/company/thestateofmedtech/ Instagram: https://www.instagram.com/stateofmedtech/ TikTok: https://www.tiktok.com/@stateofmedtechpod X: https://x.com/stateofmedtech Facebook: https://www.facebook.com/stateofmedtech FOLLOW OMAR M. KHATEEBLinkedIn: https://www.linkedin.com/in/okhateeb/ Instagram: https://www.instagram.com/omar.m.khateeb/ TikTok: https://www.tiktok.com/@omar.m.khateeb X: https://x.com/OmarMKhateeb Facebook: https://www.facebook.com/OmarMKhateeb Watch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf Join Omar at Medtech CEO Camp in Boston https://www.campcuriae.com/ #sleepapnea #sleeptechnology #medtech #digitalhealth #healthcareinnovation
Listen Show Notes
Episode #406
406.Why Most MedTech Investor Decks Fail and What Actually Persuades
Aug 12, 202652 minS1
In this solo episode, Omar Khateeb explains why most MedTech investor decks fail to create conviction and how founders can build presentations that make the market opportunity, adoption path, and use of capital clear. A strong pitch deck is more than a sequence of product, market, competition, team, and financial slides. It is an exercise in market engineering and persuasion. Investors need to see not only that the technology works, but also how the market will understand, adopt, and scale around it. Omar breaks down category design, investor psychology, market readiness, traction, commercialization, competition, business models, and storytelling. He explains how to define what your product replaces, what market shift is underway, why it is happening now, and why your company can lead it. A key lesson is the difference between activity and repeatability. Real traction reveals patterns of demand: similar hospital adoption, rising utilization, recurring revenue, shorter sales cycles, stronger physician advocacy, or customers continuing after an initial study. Learn how to make every slide lead naturally to the investor’s next question and connect each funding round to the evidence your company must create. Disclaimer: This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. The views expressed do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified professionals before making decisions. Episode Breakdown: 00:00 How to Build an Investor Deck That Gets Attention 01:12 Intro + Why Investor Presentations Matter 02:47 What Founders Need to Know Before Pitching 05:01 Why Most Investor Decks Get the Strategy Wrong 07:28 How to Move Investors From Uncertainty to Conviction 09:18 Market Engineering and the Investor Story 11:05 Define the Market Before You Pitch the Product 13:25 Why Investors Need a Clear Category 15:30 Stop Selling Features and Start Selling Market Change 19:15 The Psychology of Attention and Memory 21:55 Why Now Is Critical to Your Investor Pitch 24:03 Product Market Fit vs Market Readiness 26:01 How to Explain Complex MedTech Simply 29:12 Show Investors Proof, Not Noise 31:04 What Real Traction Looks Like 32:23 How to Prove Repeatable Market Demand 35:01 What Your Funding Round Should Actually Prove 37:05 A Better Way to Present Market Opportunity 39:15 How to Position Against Competitors 41:16 Turning Adoption Into a Business Model 43:43 How Market Signals Show Growing Demand 45:12 Sell Investors the Future, Not Just the Product 47:10 How to Build a Stronger Team and Funding Story 48:18 How Every Investor Deck Should Flow 50:01 Final Investor Pitch Lessons 51:03 Outro Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit https://GrowMyMedtech.com to book a free analysis. SUBSCRIBE YouTube: https://www.youtube.com/@thestateofmedtech LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/ FOLLOW THE STATE OF MEDTECH LinkedIn: https://www.linkedin.com/company/thestateofmedtech/ Instagram: https://www.instagram.com/stateofmedtech/ TikTok: https://www.tiktok.com/@stateofmedtechpod X: https://x.com/stateofmedtech Facebook: https://www.facebook.com/stateofmedtech FOLLOW OMAR M. KHATEEB LinkedIn: https://www.linkedin.com/in/okhateeb/ Instagram: https://www.instagram.com/omar.m.khateeb/ TikTok: https://www.tiktok.com/@omar.m.khateeb X: https://x.com/OmarMKhateeb Facebook: https://www.facebook.com/OmarMKhateeb Watch Omar’s Market Engineering Training: ⁠⁠https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf⁠⁠ Join Omar at Medtech CEO Camp in Boston: ⁠⁠https://www.campcuriae.com/ #medtech #investorpitch #fundraising #startupstrategy #marketanalysis
Listen Show Notes
Episode #405
405. Venture: Neurotech’s Next Billion-Dollar Breakthrough with Amy Kruse of Satori Capital
Aug 10, 20261h 10mS1
In this episode, Omar Khateeb speaks with Amy Kruse, General Partner and Chief Investment Officer at Satori Neuro, about the intersection of neuroscience, neurotechnology, AI, brain health innovation, and venture capital. A neuroscientist, DARPA leader, defense executive, entrepreneur and investor, Amy explains Satori Neuro's ecosystem approach. Interests include neuromodulation, precision psychiatry, biomarkers, digital therapeutics, psychedelics, the gut-brain axis, diagnostics and access to care. The conversation explores systems-level neuroscience and targeted interventions such as TMS, tDCS and low-intensity focused ultrasound. Amy shares how imaging, biomarkers, personalized therapies, and neuromodulation could move psychiatry toward care designed around each patient. Omar and Amy also discuss AI brain models, multimodal data, proprietary datasets, defensible platforms, brain-computer interfaces, closed-loop systems, sleep tech, consumer devices, cash-pay care, and pathways that could bring advanced treatments into homes and local clinics. For founders and investors, Amy explains clinical milestones, seed and Series A expectations, tranche financing, investor pitches, market pull, and why excellent science needs a credible commercialization strategy. DISCLAIMER This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions. EPISODE BREAKDOWN 00:00 Why Neurotechnology Is Entering a New Era 00:51 Intro + Meet Amy Kruse 02:57 From DARPA Neuroscience to Venture Capital 07:07 Satori Neuro's Investment Thesis 10:05 Market Engineering + MedTech Commercialization 13:09 Precision Psychiatry and Targeted Brain Therapies 16:29 AI and Foundation Models for the Brain 18:27 What Creates a Defensible AI Moat? 20:13 Why the US Needs to Invest in Neurotechnology 22:34 The Future of Brain-Computer Interfaces 25:14 Building the Next Neurotech Giant 29:21 Why Neurotech Needs Platform Companies 31:30 Brain-Computer Interfaces and Pharma 34:14 Why Reimbursement Isn't the Only Path 38:08 Bringing Neurotechnology Closer to Patients 41:01 What MedTech Founders Need to Know About Fundraising 44:10 What Makes an Early-Stage Startup Investable? 45:49 Why Great Science Alone Isn't Enough 47:14 The Biggest Founder Pitching Mistakes 49:38 A Better Way to Pitch Investors 53:05 The Wildest Investor Pitch Story 54:30 Neuroplasticity and Neuromodulation 57:49 Consumer Neurotech and Human Performance 01:00:10 Why Consumer Neurotech Hasn't Exploded Yet 01:01:23 The Billion-Dollar Opportunity in Sleep Tech 01:03:36 Why Neurotech Form Factor Matters 01:05:11 Rapid Fire + Amy's Favorite Health Tech 01:07:27 The Future of Precision Brain Medicine 01:08:58 Final Thoughts 01:09:30 Outro Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis. SUBSCRIBE YouTube: https://www.youtube.com/@thestateofmedtech LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/ FOLLOW THE STATE OF MEDTECH LinkedIn: https://www.linkedin.com/company/thestateofmedtech/ Instagram: https://www.instagram.com/stateofmedtech/ TikTok: https://www.tiktok.com/@stateofmedtechpod X: https://x.com/stateofmedtech Facebook: https://www.facebook.com/stateofmedtech FOLLOW OMAR M. KHATEEB LinkedIn: https://www.linkedin.com/in/okhateeb/ Instagram: https://www.instagram.com/omar.m.khateeb/ TikTok: https://www.tiktok.com/@omar.m.khateeb X: https://x.com/OmarMKhateeb Facebook: https://www.facebook.com/OmarMKhateeb #neurotechnology #brainhealth #neuromodulation #medtech #healthcareinnovation
Listen Show Notes
Episode #404
404.Peter Thiel's Company Building Framework Every MedTech Founder Should Master
Aug 5, 202641 minS1
In this solo episode, Omar Khateeb examines Peter Thiel’s most overlooked lesson for MedTech founders: breakthrough technology does not create its own path to customers, investors, clinicians, or commercial adoption. Drawing from the sales and distribution chapter of Zero to One , Omar explains why commercialization begins long before FDA clearance or product launch. A MedTech company is already selling when it recruits employees, raises capital, engages physician advisors, secures clinical partners, and asks hospitals to support a future that has not yet been fully proven. The discussion explores why genuinely innovative technologies require sophisticated market education, how founders can reduce uncertainty across complex hospital buying decisions, and why technical differentiation must be supported by a credible narrative, economic case, adoption strategy, and distribution model. Omar also examines fundraising, category creation, investor confidence, physician advocacy, early adopters, recruiting, public relations, and market engineering.Ultimately, the episode argues that founders must build belief before they can build revenue. The companies that understand this early create stronger organizations, attract better talent, earn greater investor confidence, and give meaningful healthcare innovation a credible path toward patients. This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown: 00:00 Why Great MedTech Products Still Fail 01:04 Intro + Peter Thiel's Biggest Lesson 03:51 Why Every Founder Is Always Selling 06:05 Getting Comfortable With Rejection 06:58 The Most Overlooked Chapter in Zero to One 11:27 Why Market Engineering Matters 13:34 If You Build It, Will They Come? 15:12 Why Distribution Is Part of Product Design 18:05 Why New Categories Need Better Storytelling 21:10 The Biggest Sales Mistake MedTech Founders Make 24:30 Why Selling Is Really About Building Belief 27:10 Your Biggest Competitor Is Doing Nothing 31:24 Market Engineering Starts Before Launch 32:45 Why Founders Must Sell to Investors and Employees 34:47 The Hidden Power of PR and Reputation 38:05 The First Thing You Sell Is Belief 39:38 Final Lessons From Zero to One 41:00 Outro Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis. Subscribe to our Youtube Channel https://www.youtube.com/@thestateofmedtech Subscribe to our LinkedIn Newsletter https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/ Follow The State of MedTech on LinkedIn https://www.linkedin.com/company/thestateofmedtech/ Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod X https://x.com/stateofmedtech Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech Follow Omar M. Khateeb on LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok https://www.tiktok.com/@omar.m.khateeb X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.facebook.com/OmarMKhateeb #medtech #startupstrategy #marketanalysis #gotomarket #peterthiel
Listen Show Notes
Episode #403
403.How Mike Minogue Built Abiomed Into a $17B MedTech Unicorn and Now Wants to be Massachusetts' Next Governor
Aug 3, 202648 minS1
Michael Minogue, 2026 Republican Endorsed Candidate for Governor of Massachusetts , President and CEO of Minogue Consulting , and former CEO of Abiomed , joins Omar Khateeb to share the leadership principles behind one of MedTech's most remarkable growth stories. The conversation explores how Abiomed evolved from a struggling company into a $17 billion MedTech leader by creating an entirely new category around heart recovery rather than competing within an existing market. Michael explains how leadership, commercialization, physician adoption, innovation, culture, disciplined execution, and patient first thinking combined to establish a new global standard of care while delivering extraordinary clinical and business outcomes. Together, they discuss category leadership, cardiovascular innovation, crisis management, organizational culture, regulatory strategy, data driven improvement, leadership under pressure, talent development, servant leadership, and why the greatest healthcare companies are built by leaders who remain obsessed with continuous improvement, long term value creation, and patient impact. This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown: 00:00 How Abiomed Became a $17 Billion MedTech Success 01:23 Intro + Meet Former Abiomed CEO Mike Minogue 04:30 The Vision That Changed Abiomed Forever 08:41 Why Heart Recovery Beat Heart Replacement 12:20 Creating a New Standard of Care 14:39 Building the Heart Recovery Category 16:47 Engineering a Market, Not Just a Product 17:06 Learn, Adapt, Execute 21:54 How Data Improved Patient Survival 25:25 The Hardest Leadership Lesson 26:20 Ranger School and Building Mental Toughness 31:20 Surviving a Two Year Attack on the Company 34:05 Turning Crisis Into Competitive Advantage 37:52 Why Mike Chose Public Service 41:18 Running a State Like a Business 44:54 Leadership, Service, and the Future of Massachusetts 46:46 One Message for Every Entrepreneur 48:00 Outro Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis. Subscribe to our Youtube Channel https://www.youtube.com/@thestateofmedtech Subscribe to our LinkedIn Newsletter https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/ Follow The State of MedTech on LinkedIn https://www.linkedin.com/company/thestateofmedtech/ Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod X https://x.com/stateofmedtech Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech Follow Omar M. Khateeb on LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok https://www.tiktok.com/@omar.m.khateeb X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.facebook.com/OmarMKhateeb #heartrecovery #medtech #medicaldevices #leadership #healthcareinnovation
Listen Show Notes

Guest Appearances

Recent guests on State of Medtech. Study who booked and why before you pitch.

Peter Verrillo

Redefine Surgery

Harry Glorikian

Scientia Ventures

Advertisers on this show

Sponsor detection runs nightly. Check back soon.

Best industries to pitch State of Medtech for

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Healthstrong

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.

Podcasts like State of Medtech

All podcasts More health Top in US Top 100 by Booking Probability Booking Probability Index How scoring works How to get on podcasts

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.

FAQs

Every question we get asked before
someone starts their trial.

If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.

What is the difference between Founder Solo and Founder Pro?

Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.

How do agency tiers work?

Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.

What is a talent profile?

A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.

Can I switch plans later?

Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.

Do you offer a free trial?

Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.

What happens if I cancel?

You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.

Is the 20% annual discount automatic?

Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.

What if I have more than 50 profiles or 20 clients?

That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.

Episode #404

404.Peter Thiel's Company Building Framework Every MedTech Founder Should Master

Aug 5, 202641 minS1

In this solo episode, Omar Khateeb examines Peter Thiel’s most overlooked lesson for MedTech founders: breakthrough technology does not create its own path to customers, investors, clinicians, or commercial adoption. Drawing from the sales and distribution chapter of Zero to One , Omar explains why commercialization begins long before FDA clearance or product launch. A MedTech company is already selling when it recruits employees, raises capital, engages physician advisors, secures clinical partners, and asks hospitals to support a future that has not yet been fully proven. The discussion explores why genuinely innovative technologies require sophisticated market education, how founders can reduce uncertainty across complex hospital buying decisions, and why technical differentiation must be supported by a credible narrative, economic case, adoption strategy, and distribution model. Omar also examines fundraising, category creation, investor confidence, physician advocacy, early adopters, recruiting, public relations, and market engineering.Ultimately, the episode argues that founders must build belief before they can build revenue. The companies that understand this early create stronger organizations, attract better talent, earn greater investor confidence, and give meaningful healthcare innovation a credible path toward patients. This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown: 00:00 Why Great MedTech Products Still Fail 01:04 Intro + Peter Thiel's Biggest Lesson 03:51 Why Every Founder Is Always Selling 06:05 Getting Comfortable With Rejection 06:58 The Most Overlooked Chapter in Zero to One 11:27 Why Market Engineering Matters 13:34 If You Build It, Will They Come? 15:12 Why Distribution Is Part of Product Design 18:05 Why New Categories Need Better Storytelling 21:10 The Biggest Sales Mistake MedTech Founders Make 24:30 Why Selling Is Really About Building Belief 27:10 Your Biggest Competitor Is Doing Nothing 31:24 Market Engineering Starts Before Launch 32:45 Why Founders Must Sell to Investors and Employees 34:47 The Hidden Power of PR and Reputation 38:05 The First Thing You Sell Is Belief 39:38 Final Lessons From Zero to One 41:00 Outro Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis. Subscribe to our Youtube Channel https://www.youtube.com/@thestateofmedtech Subscribe to our LinkedIn Newsletter https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/ Follow The State of MedTech on LinkedIn https://www.linkedin.com/company/thestateofmedtech/ Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod X https://x.com/stateofmedtech Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech Follow Omar M. Khateeb on LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok https://www.tiktok.com/@omar.m.khateeb X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.facebook.com/OmarMKhateeb #medtech #startupstrategy #marketanalysis #gotomarket #peterthiel

Listen Show Notes

Every question we get asked before
someone starts their trial.

If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.

What is the difference between Founder Solo and Founder Pro?

How do agency tiers work?

What is a talent profile?

Can I switch plans later?

Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.

Do you offer a free trial?

Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.

What happens if I cancel?

You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.

Is the 20% annual discount automatic?

Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.

What if I have more than 50 profiles or 20 clients?

That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.

State of Medtech

About this Podcast:

Pitch Analysis

What is State of Medtech?

About the host

Recent episodes

407. The Sleep Apnea Treatment Renaissance: Amir Reuveny, CEO of Wesper, on Reinventing Diagnosis

406.Why Most MedTech Investor Decks Fail and What Actually Persuades

405. Venture: Neurotech’s Next Billion-Dollar Breakthrough with Amy Kruse of Satori Capital

404.Peter Thiel's Company Building Framework Every MedTech Founder Should Master

403.How Mike Minogue Built Abiomed Into a $17B MedTech Unicorn and Now Wants to be Massachusetts' Next Governor

Guest Appearances

Peter Verrillo

Harry Glorikian

Advertisers on this show

Best industries to pitch State of Medtech for

Podcasts like State of Medtech

Every question we get asked beforesomeone starts their trial.

State of Medtech

About this Podcast:

Pitch Analysis

What is State of Medtech?

About the host

Recent episodes

407. The Sleep Apnea Treatment Renaissance: Amir Reuveny, CEO of Wesper, on Reinventing Diagnosis

406.Why Most MedTech Investor Decks Fail and What Actually Persuades

405. Venture: Neurotech’s Next Billion-Dollar Breakthrough with Amy Kruse of Satori Capital

404.Peter Thiel's Company Building Framework Every MedTech Founder Should Master

403.How Mike Minogue Built Abiomed Into a $17B MedTech Unicorn and Now Wants to be Massachusetts' Next Governor

Guest Appearances

Peter Verrillo

Harry Glorikian

Advertisers on this show

Best industries to pitch State of Medtech for

Podcasts like State of Medtech

Every question we get asked beforesomeone starts their trial.

Every question we get asked before
someone starts their trial.

Every question we get asked before
someone starts their trial.